오늘의 주요 종목뉴스

[카이로스k]

'나노의약품 개발' 인벤테라, 코스닥 데뷔[오늘 상장]

https://www.edaily.co.kr/News/Read?newsId=02423926645412184&mediaCodeNo=257&OutLnkChk=Y

[인벤테라]

 

 

엔비디아, 美 AI반도체 설계업체에 3조원 투자

https://www.donga.com/news/Economy/article/all/20260401/133656840/2

[우리로, 빛과전자, 대한광통신, 오이솔루션, 파이버프로, 우리로, 코위버, 에이스테크, 라이콤, 머큐리, 

광전자, 자람테크놀로지 등]

 

 

AI 패러다임, '학습'→'추론'… 메모리 병목 해소할 '경량화' 기술 부상

https://www.edaily.co.kr/News/Read?newsId=05402166645411856&mediaCodeNo=257&OutLnkChk=Y

[노타 등]

 

 

파라텍, 463억 규모 공급계약 체결

https://www.edaily.co.kr/News/Read?newsId=05976166645411856&mediaCodeNo=257&OutLnkChk=Y

[파라텍]

 

 

타법인 주식 및 출자증권 처분결정

https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260401800918

[일신방직]

 

 

[속보] 54년 만에 다시 달로…유인 우주선 아르테미스 2호 발사

https://www.joongang.co.kr/article/25416922

[ 인텔리안테크, 이노스페이스, 컨텍, 스피어, 나라스페이스 등]

 

 

[단독] SK에코플랜트, 금리 7.5% 주고 FI들 지분 되산다

https://www.chosun.com/economy/stock-finance/2026/04/02/GU2DONRUME2TOZLCMJSWKZBQGM/

[SK에코플랜트]

 

 

비만약 시장 100조 전망에 제약·바이오 '묻지마 탑승'

https://www.hankyung.com/article/2026040126041

[디앤디파마텍, 인벤티지랩, 펩트론, 지투지바이오 등]

 

 

'미확정' 공시 23번에 R&D 축소…삼천당제약, 신뢰 논란 속 고발 대응

https://www.chosun.com/economy/science/2026/04/02/HBSWCZRZMYZWKOBVGJSDGODGGU/

[삼천당제약]

 

 

팬젠, 세포기반 활성분석 서비스 사업 확장

https://www.joongang.co.kr/article/25416777

[팬젠]

 

 

삼성바이오로직스, 미국 첫 생산기지 마련

https://www.joongang.co.kr/article/25416833

[삼성바이오로직스]

 

 

LG CNS, 로봇 도입 컨설팅…최적의 작업 순서 설계

https://www.hankyung.com/article/2026040125401

[LG CNS]

 

 

'탱커 집중' 대한조선, 영업이익률 30% 넘어서나

https://www.hankyung.com/article/2026040126151

[대한조선]

 

 

한화, K9 앞세워 美육군 '노크' … 유럽선 무기 생산기반 구축도

https://www.hankyung.com/article/2026040126151

[한화에어로스페이스]

 

 

중국인들 정말 줄지어 오더니...제주 드림타워, 3월 매출 500억원대 첫 달성

https://www.mk.co.kr/news/business/12005230

[롯데관광개발]

 

 

수출 30% 급등… 美 사로잡은 동원참치

https://www.donga.com/news/Economy/article/all/20260401/133648705/2

[동원F&B]

 

 

LX인터내셔널, 인니 재생에너지 확 키운다

https://www.mk.co.kr/news/business/12005257

[LX인터내셔널]

 

 

한화솔루션 ‘빚 갚기 유증’ 논란 계속..."계열사가 인수하라" 요구도

https://www.joongang.co.kr/article/25416737

[한화솔루션]

 

 

LG화학, 미개척 표적 겨냥 혁신 항암제 도전

https://www.sedaily.com/article/20027231

[LG화학]

 

 

삼성重도 마스가 ‘깃발’…美군함 수주 경쟁 가세

https://www.sedaily.com/article/20027164

[삼성중공업]

 

 

LG전자 ‘정년 후 재고용’도입…평균 임금인상률 4%

https://www.joongang.co.kr/article/25416752

[LG전자]

 

 

SK하이닉스 ‘세계 가장 윤리적 기업’ 2년 연속 올라

https://www.donga.com/news/Economy/article/all/20260401/133656849/2

[SK하이닉스]

 

 

삼성 갤럭시S26 울트라, 유럽 7개국 소비자 평가 1위 '싹쓸이'

https://www.edaily.co.kr/News/Read?newsId=02650246645412184&mediaCodeNo=257

[삼성전자]

 

 

기아, 英 '톱기어 EV 어워즈' 최고의 제조사

https://www.hankyung.com/article/2026040126101

[기아]